Budd-Chiari Syndrome: An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed

Clin Liver Dis. 2020 Aug;24(3):453-481. doi: 10.1016/j.cld.2020.04.012. Epub 2020 Jun 2.

Abstract

Budd-Chiari syndrome (BCS), or hepatic venous outflow obstruction, is a rare cause of liver disease that should not be missed. Variable clinical presentation among patients with BCS necessitates a high index of suspicion to avoid missing this life-threatening diagnosis. BCS is characterized as primary or secondary, depending on etiology of venous obstruction. Most patients with primary BCS have several contributing risk factors leading to a prothrombotic state. A multidisciplinary stepwise approach is integral in treating BCS. Lifelong anticoagulation is recommended. Long-term monitoring of patients for development of cirrhosis, complications of portal hypertension, hepatocellular carcinoma, and progression of underlying diseases is important.

Keywords: Angioplasty; Anticoagulation; Hepatic venous outflow tract obstruction; Portal shunt; Splanchnic thrombosis; Thrombophilia; Transjugular intrahepatic portosystemic shunt; Transplantation.

Publication types

  • Review

MeSH terms

  • Angioplasty
  • Anticoagulants / therapeutic use
  • Budd-Chiari Syndrome / diagnosis*
  • Budd-Chiari Syndrome / epidemiology
  • Budd-Chiari Syndrome / etiology
  • Budd-Chiari Syndrome / therapy*
  • Decompression, Surgical
  • Humans
  • Liver Transplantation
  • Myeloproliferative Disorders / complications
  • Portasystemic Shunt, Transjugular Intrahepatic
  • Prognosis
  • Risk Factors
  • Stents
  • Thrombophilia / complications

Substances

  • Anticoagulants

Supplementary concepts

  • Thrombophilia, hereditary